结局变量,N,治疗效应系数,标准误,95%CI下限,95%CI上限,P值,R²,显著,控制变量,解释
ALT变化,171,-1.0483979088259952,1.7078614458954802,-4.420477477467297,2.323681659815306,0.5401493488521518,0.045636770534412174,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组ALT变化无显著减少1.05单位
AST变化,171,0.6311968264764498,1.4081910647501141,-2.14919986764607,3.411593520598969,0.6545735185569656,0.028564476762478752,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组AST变化无显著增加0.63单位
肝硬度变化,126,-0.8175628910897607,0.5369266196006768,-1.8806402305193468,0.2455144483398254,0.13047181912997202,0.4374467867552517,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组肝硬度变化无显著减少0.82单位
